Ładuje się......
Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis
AIMS: To investigate the overall incidence and risk of hypertension in cancer patients who receive axitinib and compare the differences in incidences between axitinib and the other four approved vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs). METHODS: Several d...
Zapisane w:
Główni autorzy: | , , , |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
Blackwell Science Inc
2013
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3769663/ https://ncbi.nlm.nih.gov/pubmed/23617405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12149 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|